Stay updated on Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.

Latest updates to the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page
- Check2 days agoChange DetectedReplaced Padua, Italy, 35128 with Padova, Italy, 35128 in the location entry to reflect the correct city name.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedNaples, Italy (80131) was added to the list of study locations and Napoli was replaced with Naples. The page also shows a new Revision: v3.5.0.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page.SummaryDifference0.0%

- Check53 days agoChange DetectedFooter revision label updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded a glossary toggle (Show glossary) and a new Revision: v3.4.0, along with minor metadata wording/capitalization changes (e.g., Last Update Submitted that Met QC Criteria and No FEAR Act Data).SummaryDifference0.2%

Stay in the know with updates to Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab vs Chemo/Nivolumab in SqLC Clinical Trial page.